This educational activity will focus on the identification and management of oral and swallowing complications caused by cancer-directed therapy for patients with head and neck cancer.

The gaps in practice include the proper integration of new data with existing trials and practices in viral-driven head and neck cancers.

This session reviews head and neck cancers from a patient perspective.

This case-based panel will outline the multidisciplinary approach to patients with salivary cancer.  Perspective will be provided by experts in the field on topics such as extent of primary tumor surgery and management of cervical lymphatics, as well as indications for adjuvant radiation therapy

There is a great need for improvement in outcomes for HPV negative HNSCC patients. There are ongoing efforts to better understand the biology of HPV negative HNSCC, and reported and ongoing therapeutic clinical trials to try to improve outcomes in this patient population.

The treatment of early and advanced thyroid cancer is rapidly changing due to developments in targeted drug therapy and new surgical and minimally invasive approaches.  This session will familiarize the learner with the new targeted agents and their appropriate place in the treatment algorithms. 

This session will review the latest science in the field of head and neck cancer.

There are many ongoing advances in neoadjuvant immunotherapy in curative-intent head and neck cancer, yet optimal incorporation and biomarkers remain undefined.

Advanced cutaneous SCC is becoming more prevalent, with more aggressive disease noted.

This session reviews head and neck cancers from a patient perspective.